SEARCH:   Advanced

Erratum for Duvic et al., Blood 109 (1) 31-39. Blood, 15 June 2007, Vol. 109, No. 12, pp. 5086. This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  ERRATUM Erratum for Duvic et al., Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL) In the article by Duvic et al entitled "Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)," which appeared in the January 1, 2007, issue of Blood (Volume 109:31–39), Table 6 contained 4 inaccurate column subheadings. The 4 subheadings under "All patients by grade" should have been "Grade 1," "Grade 2," "Grade 3," and "Grade 4." CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                   What's this?

	Blood Online is supported in part by Genentech BioOncology and Biogen Idec
	Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020